Both research groups conclude that helicase-primase inhibitors are more potent than acyclovir and its derivatives.
无论研究小组断定旋-引抑制剂更烈性比阿昔洛韦及其衍生物.
Both research groups conclude that helicase-primase inhibitors are more potent than acyclovir and its derivatives.
无论研究小组断定旋-引抑制剂更烈性比阿昔洛韦及其衍生物.
声明：以上
、词性分类均由互联网资源自动生成，部分未经过人工审核，其
达内容亦不代
软件的观点；若发现问题，欢迎向我们指正。
